LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "benefit" as a keyword



A Measured Approach to Vena Cava Filter Use-Respect Rather Than Regret.

Sign Up to like & get
recommendations! Published in 2017 at "JAMA cardiology"

DOI: 10.1001/jamacardio.2016.3882

Abstract: Is there enough evidence to support the use of inferior vena cava filters?—Yes. There is a strong effort among many physicians to avoid the use of inferior vena cava filters (IVCFs) in the treatment of… read more here.

Keywords: therapy; benefit; vena cava; use ... See more keywords

Statins for Primary Cardiovascular Disease Prevention: Time to Curb Our Enthusiasm.

Sign Up to like & get
recommendations! Published in 2022 at "JAMA internal medicine"

DOI: 10.1001/jamainternmed.2022.3204

Abstract: In the US, more than 126 million adults have been diagnosed with cardiovascular disease (CVD).1 Reducing the morbidity and mortality associated with CVD is a public health imperative. Accordingly, considerable resources and effort have been… read more here.

Keywords: prevention; cause mortality; risk; benefit ... See more keywords

Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma

Sign Up to like & get
recommendations! Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2021.47375

Abstract: Key Points Question What patient characteristics are associated with benefit from treatment with COVID-19 convalescent plasma (CCP)? Findings This prognostic study of 2287 patients hospitalized with COVID-19 identified a combination of baseline characteristics that predict… read more here.

Keywords: benefit; treatment; convalescent plasma; treatment benefit ... See more keywords

Examination of Differences in Nonmedical Supplemental Benefit Coverage for Dual-Eligible Enrollees in Medicare Advantage Plans in 2021

Sign Up to like & get
recommendations! Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2022.35161

Abstract: This cross-sectional study uses Medicare Advantage benefit package data for 2021 to examine differences in the coverage of nonmedical supplemental benefits—such as transportation services and food and meal assistance—for dual-eligible enrollees with health-related social needs. read more here.

Keywords: dual eligible; eligible enrollees; medicare advantage; benefit ... See more keywords

Is Lung Cancer Screening Reaching the People Who Are Most Likely to Benefit?

Sign Up to like & get
recommendations! Published in 2022 at "JAMA network open"

DOI: 10.1001/jamanetworkopen.2022.43171

Abstract: Lung cancer remains the leading cause of cancer death in the US, largely because most patients have advanced, incurable disease at the time of diagnosis. Lung cancer screening with low-dose computed tomography (LDCT) therefore has… read more here.

Keywords: lung cancer; lung; cancer screening; benefit ... See more keywords

Individual- and Group-Level Disparities Between Racial and Ethnic Groups in Lung Cancer Screening Eligibility Criteria

Sign Up to like & get
recommendations! Published in 2025 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2025.2172

Abstract: Key Points Question How do lung cancer screening eligibility and associated benefits differ when policymakers prioritize (1) equal percentage eligibility or benefit across self-reported racial and ethnic subgroups and (2) equal individual-level eligibility criteria based… read more here.

Keywords: benefit; lung cancer; ethnic groups; racial ethnic ... See more keywords

Birth and Early Childhood Outcomes in Families Receiving an Unconditional Prenatal Cash Benefit

Sign Up to like & get
recommendations! Published in 2025 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2025.26996

Abstract: Key Points Question Do participants in the Healthy Baby Prenatal Benefit Program still have improved birth and early childhood outcomes compared with nonparticipants, despite no change in the benefit amount over the last 20 years?… read more here.

Keywords: childhood outcomes; benefit; early childhood; birth early ... See more keywords

Assessment of Whether the American Society of Clinical Oncology's Value Framework and the European Society for Medical Oncology's Magnitude of Clinical Benefit Scale Measure Absolute or Relative Clinical Survival Benefit: A Meta-analysis of Randomized Clinical Trials.

Sign Up to like & get
recommendations! Published in 2019 at "JAMA oncology"

DOI: 10.1001/jamaoncol.2019.0818

Abstract: Importance The American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO) have independently published value frameworks. To date, whether the clinical benefit scoring algorithms from these framework were intended to… read more here.

Keywords: benefit; difference; framework; survival ... See more keywords

Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC

Sign Up to like & get
recommendations! Published in 2023 at "Molecular Oncology"

DOI: 10.1002/1878-0261.13409

Abstract: Immune checkpoint inhibitors (ICIs) targeting the PD‐1/PD‐L1 axis are the main therapeutic option for patients with advanced non‐small cell lung cancer (NSCLC) without a druggable oncogenic alteration. Nevertheless, only a portion of patients benefit from… read more here.

Keywords: whole genome; checkpoint inhibitors; genome sequencing; benefit ... See more keywords

Survival benefit stratification of partial nephrectomy versus non‐surgical treatment in elderly patients with T1a renal cell carcinoma

Sign Up to like & get
recommendations! Published in 2023 at "Cancer Medicine"

DOI: 10.1002/cam4.5580

Abstract: Renal cell carcinoma (RCC) of stage T1a has been proven to be of low‐grade malignancy and mostly affects elderly individuals with relatively limited life expectancy. However, research on the survival benefit of surgery relative to… read more here.

Keywords: cell carcinoma; renal cell; survival benefit; non surgical ... See more keywords

Clinical benefit and fragility evaluation of systemic therapy trials for advanced soft tissue sarcoma

Sign Up to like & get
recommendations! Published in 2024 at "Cancer"

DOI: 10.1002/cncr.35564

Abstract: The clinical benefit of systemic anticancer therapies can be unclear despite positive trials, and outcomes may not translate to real‐world practice. This study evaluated the benefit of soft tissue sarcoma (STS) treatments using the European… read more here.

Keywords: tissue sarcoma; benefit; clinical benefit; benefit fragility ... See more keywords